Pemphigus

M Kasperkiewicz, CT Ellebrecht, H Takahashi… - Nature reviews Disease …, 2017 - nature.com
Pemphigus is a group of IgG-mediated autoimmune diseases of stratified squamous
epithelia, such as the skin and oral mucosa, in which acantholysis (the loss of cell adhesion) …

Bullous pemphigoid

D Miyamoto, CG Santi, V Aoki… - Anais brasileiros de …, 2019 - SciELO Brasil
Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects
elderly individuals. Increase in incidence rates in the past decades has been attributed to …

[HTML][HTML] Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database

S Nguengang Wakap, DM Lambert, A Olry… - European journal of …, 2020 - nature.com
Rare diseases, an emerging global public health priority, require an evidence-based
estimate of the global point prevalence to inform public policy. We used the publicly …

[HTML][HTML] Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment

V Di Lernia, DM Casanova, M Goldust… - Dermatology practical & …, 2020 - ncbi.nlm.nih.gov
Autoimmune bullous disorders are a heterogeneous spectrum of skin disorders
characterized by the production of autoantibodies against adhesion molecules of the skin …

Enhancing equitable access to rare disease diagnosis and treatment around the world: a review of evidence, policies, and challenges

T Adachi, AW El-Hattab, R Jain… - International journal of …, 2023 - mdpi.com
This document provides a comprehensive summary of evidence on the current situation of
rare diseases (RDs) globally and regionally, including conditions, practices, policies, and …

Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy

A Buonavoglia, P Leone, R Dammacco, G Di Lernia… - Autoimmunity …, 2019 - Elsevier
Pemphigus diseases (PDs) and mucous membrane pemphigoid (MMP) are a group of
immune-mediated mucocutaneous disorders clinically characterized by the formation of …

Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats

B Arzi, E Mills-Ko, FJM Verstraete, A Kol… - Stem cells …, 2016 - academic.oup.com
Mesenchymal stem cells (MSCs) are a promising therapy for immune-mediated and
inflammatory disorders, because of their potent immunomodulatory properties. In this study …

[HTML][HTML] Challenges in research and health technology assessment of rare disease technologies: report of the ISPOR rare disease special interest group

S Nestler-Parr, D Korchagina, M Toumi, CL Pashos… - Value in Health, 2018 - Elsevier
Background Successful development of new treatments for rare diseases (RDs) and their
sustainable patient access require overcoming a series of challenges related to research …

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

E Chiquette, EA Oral, A Garg… - … syndrome and obesity …, 2017 - Taylor & Francis
Background Lipodystrophy (LD; non-human immunodeficiency virus [HIV]-associated)
syndromes are a rare body of disorders for which true prevalence is unknown. Prevalence …

The global incidence of bullous pemphigoid: a systematic review and meta‐analysis

MSM Persson, N Begum, MJ Grainge… - British Journal of …, 2022 - academic.oup.com
Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly
affects older people. Although the disease is associated with considerable morbidity and …